Presentation showcases how Amphista’s Eclipsys® platform is enabling the development of Targeted Glue™ degraders, which recruit diverse E3 ligases, describing for the first time the degradation of ...

At ViVE 2026 in Los Angeles, Kontakt.io will demo an integrated suite of AI solutions that redefines operational efficiency across outpatient clinics, hospitals, and IDNs. The suite includes unique AI ...

Native Californian medical students are reclaiming healthcare for their communities — one pipeline program at a time — as AI/AN life expectancy sits nearly a decade below the national average.

For decades, a blood draw in a clinical lab was the only way to quantify your hormones. In 2026, that paradigm is shifting and we are seeing saliva cartridges analyzed by smartphone AI, DNA-based ...

With strong underlying market demand, European distributor and expert physician customer purchase orders are being received by the Company as its 2026 revenue guidance range increases to $1.5 million ...

Comprehensive VAX-31 Adult Phase 3 Clinical Program, Finalized in Consultation and Alignment with FDA, Advances with Three Phase 3 Studies Underway to Support Planned BLA Submission Topline Safety, To ...

In response to the societal challenge of growing electricity demand from AI data centers, Oak Ridge National Laboratory (ORNL ...

Mayo Clinic Mercy launch 10-year data collaboration enables researchers to access diverse, deidentified patient data across two major health systems.

Maneesh Goyal, chief operating officer of Mayo Clinic Platform, is a big believer in patient privacy, but not the way it has commonly come to be represented in the healthcare world: de-identified data ...